when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Approval · news · pharmadog

← back to Approval

News · Approval

648 stories

29dScribe records upsized $129M IPO to bankroll lipid-lowering genetic medsfiercebiotech

29dThis Week at FDA: Diamantas touts onshoring efforts, grants for DHTs, and moreraps

29dUpdate: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbumpbiospace

29dLilly, with new data, to seek FDA approval of obesity drug retatrutidebiopharma dive

29dFDA panel confronting peptide controversystat

29dScancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugendpoints

29dLilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 databiospace

29dGSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drugbiospace

Jul 23, 26Lilly's triple agonist heads to regulators after two more Phase 3 obesity winsendpoints

Jul 23, 26Recon: J&J nabs FDA authorization for general surgery robot; FDA urged to ban DTC drug adsraps

Jul 23, 26Euro Roundup: EMA seeks feedback on planned changes to guidance on biosimilar efficacy studiesraps

Jul 23, 26Study: Most sponsors complete postmarketing trials, publish resultsraps

Jul 23, 26FDA advisory committee backs two controversial peptidesraps

Jul 22, 26New study supports testing of Merck’s Ebola vaccine in DRC outbreakstat

Jul 22, 26GSK lung cancer drug gets speedy approval following $10.6B dealbiopharma dive

Jul 22, 26FDA approves Nuvalent's cancer drug, a week after GSK closed $10.6B buyoutendpoints

Jul 22, 26Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drugbiopharma dive

Jul 22, 26Summit and Akeso sharpen case for ivonescimab with new Western databiospace

Jul 22, 26Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drugbiospace

Jul 22, 26STAT+: Pharma tries to tamp down broad China restrictionsstat

Jul 22, 26US ‘eroding’ lead in rare diseases a matter of national security: Reportbiospace

Jul 22, 26Crystalys gets $130M to take Sobi-rivaling gout drug to marketendpoints

Jul 22, 26Crystalys nets $130M more to push gout drug through late-stage testsbiopharma dive

Jul 22, 26As Maui recovers from devastating fires, a study offers vision for new rural health modelstat

Jul 22, 26Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?stat

Jul 22, 26Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changerstat

Jul 22, 26Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readoutsbiospace

Jul 21, 26‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraisefiercebiotech

Jul 21, 26Agios scraps sickle cell drugbiopharma dive

Jul 21, 26Agios axes next-gen sickle cell candidate after it fails to best Novo’s assetbiospace

← prevpage 10 of 22next →